Protein-Bound Solute Clearance During Hemodialysis

Area of Science:

• Nephrology
• Biochemistry
• Clinical Medicine

Background:

• Protein-bound solutes indoxyl sulfate (IS) and p-cresol sulfate (p-CS) accumulate in chronic kidney disease (CKD).
• These uremic toxins negatively impact kidney and organ function.

Purpose of the Study:

• To evaluate the effectiveness of IS and p-CS clearance using low-flux hemodialysis (lfHD), high-flux hemodialysis (hfHD), and post-dilution hemodiafiltration (HDF).
• To assess IS and p-CS clearance after single sessions and 8-week cycles.
• To investigate associations between IS/p-CS levels and other biochemical markers.

Main Methods:

• Study included 21 uremic patients undergoing sequential dialysis modalities.
• Measured IS and p-CS serum levels before and after dialysis sessions.
• Analyzed associations with biochemical indices like hsCRP and protein levels.

Main Results:

• All tested modalities effectively reduced IS and p-CS levels after a single session, with greater reduction in p-CS.
• No significant differences in clearance were observed between lfHD, hfHD, and HDF.
• Clearance efficacy decreased over 8-week cycles.
• Higher hsCRP levels correlated with greater solute removal, while higher protein levels correlated with reduced removal.

Conclusions:

• Dialysis modality does not significantly impact IS and p-CS clearance.
• Initial dialysis sessions effectively reduce these toxins, but levels tend to rebound with prolonged treatment.
• Understanding toxin-binding dynamics is crucial for optimizing CKD management.